{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T11:58:30Z","timestamp":1774871910474,"version":"3.50.1"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,2,18]]},"DOI":"10.7759\/cureus.22367","type":"journal-article","created":{"date-parts":[[2022,2,18]],"date-time":"2022-02-18T19:16:21Z","timestamp":1645211781000},"source":"Crossref","is-referenced-by-count":8,"title":["Rheumatoid Arthritis and Associated Lung Diseases: A Comprehensive Review"],"prefix":"10.7759","author":[{"given":"Ahmad T","family":"Azam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oladipo","family":"Odeyinka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rasha","family":"Alhashimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sankeerth","family":"Thoota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tejaswini","family":"Ashok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vishnu","family":"Palyam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim","family":"Sange","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/art.27425","article-title":"Is the incidence of rheumatoid arthritis rising?: results from Olmsted County, Minnesota, 1955-2007","volume":"62","author":"Myasoedova E","year":"2010","unstructured":"Myasoedova E, Crowson CS, Kremers HM, Therneau TM, Gabriel SE. Is the incidence of rheumatoid arthritis rising?: results from Olmsted County, Minnesota, 1955-2007. Arthritis Rheum. 2010, 62:1576-1582. 10.1002\/art.27425","journal-title":"Arthritis Rheum"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)30173-8","article-title":"Rheumatoid arthritis","volume":"388","author":"Smolen JS","year":"2016","unstructured":"Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet. 2016, 388:2023-2038. 10.1016\/S0140-6736(16)30173-8","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a112878","article-title":"The epidemiology of rheumatoid arthritis in Rochester, Minnesota: a study of incidence, prevalence, and mortality","volume":"111","author":"Linos A","year":"1980","unstructured":"Linos A, Worthington JW, O'Fallon WM, Kurland LT. The epidemiology of rheumatoid arthritis in Rochester, Minnesota: a study of incidence, prevalence, and mortality. Am J Epidemiol. 1980, 111:87-98. 10.1093\/oxfordjournals.aje.a112878","journal-title":"Am J Epidemiol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-017-3726-1","article-title":"Prevalence of rheumatoid arthritis in the United States adult population in healthcare claims databases, 2004-2014","volume":"37","author":"Hunter TM","year":"2017","unstructured":"Hunter TM, Boytsov NN, Zhang X, Schroeder K, Michaud K, Araujo AB. Prevalence of rheumatoid arthritis in the United States adult population in healthcare claims databases, 2004-2014. Rheumatol Int. 2017, 37:1551-1557. 10.1007\/s00296-017-3726-1","journal-title":"Rheumatol Int"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2017.08.003","article-title":"Genetic and environmental risk factors for rheumatoid arthritis","volume":"31","author":"Deane KD","year":"2017","unstructured":"Deane KD, Demoruelle MK, Kelmenson LB, Kuhn KA, Norris JM, Holers VM. Genetic and environmental risk factors for rheumatoid arthritis. Best Pract Res Clin Rheumatol. 2017, 31:3-18. 10.1016\/j.berh.2017.08.003","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1172\/JCI36389","article-title":"Evidence that cytokines play a role in rheumatoid arthritis","volume":"118","author":"Brennan FM","year":"2008","unstructured":"Brennan FM, McInnes IB. Evidence that cytokines play a role in rheumatoid arthritis. J Clin Invest. 2008, 118:3537-3545. 10.1172\/JCI36389","journal-title":"J Clin Invest"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1084\/jem.162.6.2163","article-title":"Cachectin\/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts","volume":"162","author":"Dayer JM","year":"1985","unstructured":"Dayer JM, Beutler B, Cerami A. Cachectin\/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts. J Exp Med. 1985, 162:2163-2168. 10.1084\/jem.162.6.2163","journal-title":"J Exp Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/j.0105-2896.2009.00859.x","article-title":"Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis","volume":"233","author":"Bartok B","year":"2010","unstructured":"Bartok B, Firestein GS. Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis. Immunol Rev. 2010, 233:233-255. 10.1111\/j.0105-2896.2009.00859.x","journal-title":"Immunol Rev"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2016.01296","article-title":"How rheumatoid arthritis can result from provocation of the immune system by microorganisms and viruses","volume":"7","author":"Arleevskaya MI","year":"2016","unstructured":"Arleevskaya MI, Kravtsova OA, Lemerle J, Renaudineau Y, Tsibulkin AP. How rheumatoid arthritis can result from provocation of the immune system by microorganisms and viruses. Front Microbiol. 2016, 7:1296. 10.3389\/fmicb.2016.01296","journal-title":"Front Microbiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3379","article-title":"Widespread non-additive and interaction effects within HLA loci modulate the risk of autoimmune diseases","volume":"47","author":"Lenz TL","year":"2015","unstructured":"Lenz TL, Deutsch AJ, Han B, et al.. Widespread non-additive and interaction effects within HLA loci modulate the risk of autoimmune diseases. Nat Genet. 2015, 47:1085-1090. 10.1038\/ng.3379","journal-title":"Nat Genet"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/art.27272","article-title":"Smoking increases rheumatoid arthritis susceptibility in individuals carrying the HLA-DRB1 shared epitope, regardless of rheumatoid factor or anti-cyclic citrullinated peptide antibody status","volume":"62","author":"Bang SY","year":"2010","unstructured":"Bang SY, Lee KH, Cho SK, Lee HS, Lee KW, Bae SC. Smoking increases rheumatoid arthritis susceptibility in individuals carrying the HLA-DRB1 shared epitope, regardless of rheumatoid factor or anti-cyclic citrullinated peptide antibody status. Arthritis Rheum. 2010, 62:369-377. 10.1002\/art.27272","journal-title":"Arthritis Rheum"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.13103","article-title":"Diagnosis and management of rheumatoid arthritis: a review","volume":"320","author":"Aletaha D","year":"2018","unstructured":"Aletaha D, Smolen JS. Diagnosis and management of rheumatoid arthritis: a review. JAMA. 2018, 320:1360-1372. 10.1001\/jama.2018.13103","journal-title":"JAMA"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-015-0643-0","article-title":"Cervical spine involvement in rheumatoid arthritis over time: results from a meta-analysis","volume":"17","author":"Zhang T","year":"2015","unstructured":"Zhang T, Pope J. Cervical spine involvement in rheumatoid arthritis over time: results from a meta-analysis. Arthritis Res Ther. 2015, 17:148. 10.1186\/s13075-015-0643-0","journal-title":"Arthritis Res Ther"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-019-0275-x","article-title":"Mechanisms of lung disease development in rheumatoid arthritis","volume":"15","author":"Wang D","year":"2019","unstructured":"Wang D, Zhang J, Lau J, Wang S, Taneja V, Matteson EL, Vassallo R. Mechanisms of lung disease development in rheumatoid arthritis. Nat Rev Rheumatol. 2019, 15:581-596. 10.1038\/s41584-019-0275-x","journal-title":"Nat Rev Rheumatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2013.07.010","article-title":"Rheumatoid arthritis and cardiovascular disease","volume":"166","author":"Crowson CS","year":"2013","unstructured":"Crowson CS, Liao KP, Davis JM 3rd, et al.. Rheumatoid arthritis and cardiovascular disease. Am Heart J. 2013, 166:622-628.e1. 10.1016\/j.ahj.2013.07.010","journal-title":"Am Heart J"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2017.06.005","article-title":"Neurologic manifestations of rheumatoid arthritis","volume":"43","author":"DeQuattro K","year":"2017","unstructured":"DeQuattro K, Imboden JB. Neurologic manifestations of rheumatoid arthritis. Rheum Dis Clin North Am. 2017, 43:561-571. 10.1016\/j.rdc.2017.06.005","journal-title":"Rheum Dis Clin North Am"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.4103\/jpp.JPP_194_16","article-title":"An overview of the extraarticular involvement in rheumatoid arthritis and its management","volume":"8","author":"Das S","year":"2017","unstructured":"Das S, Padhan P. An overview of the extraarticular involvement in rheumatoid arthritis and its management. J Pharmacol Pharmacother. 2017, 8:81-86. 10.4103\/jpp.JPP_194_16","journal-title":"J Pharmacol Pharmacother"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3390\/cells9040880","article-title":"Update on the pathomechanism, diagnosis, and treatment options for rheumatoid arthritis","volume":"9","author":"Lin YJ","year":"2020","unstructured":"Lin YJ, Anzaghe M, Sch\u00fclke S. Update on the pathomechanism, diagnosis, and treatment options for rheumatoid arthritis. Cells. 2020, 9:880. 10.3390\/cells9040880","journal-title":"Cells"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kes279","article-title":"ACR\/EULAR 2010 rheumatoid arthritis classification criteria","volume":"51","author":"Kay J","year":"2012","unstructured":"Kay J, Upchurch KS. ACR\/EULAR 2010 rheumatoid arthritis classification criteria. Rheumatology (Oxford). 2012, 51:vi5-vi9. 10.1093\/rheumatology\/kes279","journal-title":"Rheumatology (Oxford)"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209646","article-title":"Novel algorithms for the pragmatic use of ultrasound in the management of patients with rheumatoid arthritis: from diagnosis to remission","volume":"75","author":"D'Agostino MA","year":"2016","unstructured":"D'Agostino MA, Terslev L, Wakefield R, et al.. Novel algorithms for the pragmatic use of ultrasound in the management of patients with rheumatoid arthritis: from diagnosis to remission. Ann Rheum Dis. 2016, 75:1902-1908. 10.1136\/annrheumdis-2016-209646","journal-title":"Ann Rheum Dis"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/art.41752","article-title":"2021 American College of Rheumatology guideline for the treatment of rheumatoid arthritis","volume":"73","author":"Fraenkel L","year":"2021","unstructured":"Fraenkel L, Bathon JM, England BR, et al.. 2021 American College of Rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Rheumatol. 2021, 73:1108-1123. 10.1002\/art.41752","journal-title":"Arthritis Rheumatol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2014.12.004","article-title":"Lung disease in rheumatoid arthritis","volume":"41","author":"Yunt ZX","year":"2015","unstructured":"Yunt ZX, Solomon JJ. Lung disease in rheumatoid arthritis. Rheum Dis Clin North Am. 2015, 41:225-236. 10.1016\/j.rdc.2014.12.004","journal-title":"Rheum Dis Clin North Am"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kes262","article-title":"A study of baseline prevalence and cumulative incidence of comorbidity and extra-articular manifestations in RA and their impact on outcome","volume":"52","author":"Norton S","year":"2013","unstructured":"Norton S, Koduri G, Nikiphorou E, Dixey J, Williams P, Young A. A study of baseline prevalence and cumulative incidence of comorbidity and extra-articular manifestations in RA and their impact on outcome. Rheumatology (Oxford). 2013, 52:99-110. 10.1093\/rheumatology\/kes262","journal-title":"Rheumatology (Oxford)"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2012.04.004","article-title":"Rheumatoid lung disease: prognostic analysis of 54 biopsy-proven cases","volume":"106","author":"Nakamura Y","year":"2012","unstructured":"Nakamura Y, Suda T, Kaida Y, et al.. Rheumatoid lung disease: prognostic analysis of 54 biopsy-proven cases. Respir Med. 2012, 106:1164-1169. 10.1016\/j.rmed.2012.04.004","journal-title":"Respir Med"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"McInnes IB","year":"2011","unstructured":"McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med. 2011, 365:2205-2219. 10.1056\/NEJMra1004965","journal-title":"N Engl J Med"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1002\/art.21575","article-title":"A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination","volume":"54","author":"Klareskog L","year":"2006","unstructured":"Klareskog L, Stolt P, Lundberg K, et al.. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum. 2006, 54:38-46. 10.1002\/art.21575","journal-title":"Arthritis Rheum"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0011-2021","article-title":"Rheumatoid arthritis-interstitial lung disease: manifestations and current concepts in pathogenesis and management","volume":"30","author":"Kadura S","year":"2021","unstructured":"Kadura S, Raghu G. Rheumatoid arthritis-interstitial lung disease: manifestations and current concepts in pathogenesis and management. Eur Respir Rev. 2021, 30:210011. 10.1183\/16000617.0011-2021","journal-title":"Eur Respir Rev"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2015.01.013","article-title":"Citrullination and autoimmunity","volume":"14","author":"Valesini G","year":"2015","unstructured":"Valesini G, Gerardi MC, Iannuccelli C, Pacucci VA, Pendolino M, Shoenfeld Y. Citrullination and autoimmunity. Autoimmun Rev. 2015, 14:490-497. 10.1016\/j.autrev.2015.01.013","journal-title":"Autoimmun Rev"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1002\/art.11223","article-title":"Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis","volume":"48","author":"Rantap\u00e4\u00e4-Dahlqvist S","year":"2003","unstructured":"Rantap\u00e4\u00e4-Dahlqvist S, de Jong BA, Berglin E, et al.. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum. 2003, 48:2741-2749. 10.1002\/art.11223","journal-title":"Arthritis Rheum"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00301.2018","article-title":"Profibrotic effect of IL-17A and elevated IL-17RA in idiopathic pulmonary fibrosis and rheumatoid arthritis-associated lung disease support a direct role for IL-17A\/IL-17RA in human fibrotic interstitial lung disease","volume":"316","author":"Zhang J","year":"2019","unstructured":"Zhang J, Wang D, Wang L, et al.. Profibrotic effect of IL-17A and elevated IL-17RA in idiopathic pulmonary fibrosis and rheumatoid arthritis-associated lung disease support a direct role for IL-17A\/IL-17RA in human fibrotic interstitial lung disease. Am J Physiol Lung Cell Mol Physiol. 2019, 316:487-497. 10.1152\/ajplung.00301.2018","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00092309","article-title":"Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease","volume":"35","author":"Kim EJ","year":"2010","unstructured":"Kim EJ, Elicker BM, Maldonado F, et al.. Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease. Eur Respir J. 2010, 35:1322-1328. 10.1183\/09031936.00092309","journal-title":"Eur Respir J"},{"key":"ref32","doi-asserted-by":"crossref","DOI":"10.1136\/thx.56.8.622","article-title":"Fibrosing alveolitis in patients with rheumatoid arthritis as assessed by high resolution computed tomography, chest radiography, and pulmonary function tests","volume":"56","author":"Dawson JK","year":"2001","unstructured":"Dawson JK, Fewins HE, Desmond J, Lynch MP, Graham DR. Fibrosing alveolitis in patients with rheumatoid arthritis as assessed by high resolution computed tomography, chest radiography, and pulmonary function tests. Thorax. 2001, 56:622-627.","journal-title":"Thorax"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201807-1255ST","article-title":"Diagnosis of idiopathic pulmonary fibrosis. An official ATS\/ERS\/JRS\/ALAT clinical practice guideline","volume":"198","author":"Raghu G","year":"2018","unstructured":"Raghu G, Remy-Jardin M, Myers JL, et al.. Diagnosis of idiopathic pulmonary fibrosis. An official ATS\/ERS\/JRS\/ALAT clinical practice guideline. Am J Respir Crit Care Med. 2018, 198:44-68. 10.1164\/rccm.201807-1255ST","journal-title":"Am J Respir Crit Care Med"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201308-1483ST","article-title":"An official American Thoracic Society\/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias","volume":"188","author":"Travis WD","year":"2013","unstructured":"Travis WD, Costabel U, Hansell DM, et al.. An official American Thoracic Society\/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2013, 188:733-748. 10.1164\/rccm.201308-1483ST","journal-title":"Am J Respir Crit Care Med"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1186\/s40248-019-0179-2","article-title":"Contribution of pulmonary function tests (PFTs) to the diagnosis and follow up of connective tissue diseases","volume":"14","author":"Ciancio N","year":"2019","unstructured":"Ciancio N, Pavone M, Torrisi SE, et al.. Contribution of pulmonary function tests (PFTs) to the diagnosis and follow up of connective tissue diseases. Multidiscip Respir Med. 2019, 14:17. 10.1186\/s40248-019-0179-2","journal-title":"Multidiscip Respir Med"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1164\/arrd.1986.133.3.450","article-title":"Bronchoalveolar lavage fluid evaluation in rheumatoid arthritis","volume":"133","author":"Garcia JG","year":"1986","unstructured":"Garcia JG, Parhami N, Killam D, Garcia PL, Keogh BA. Bronchoalveolar lavage fluid evaluation in rheumatoid arthritis. Am Rev Respir Dis. 1986, 133:450-454. 10.1164\/arrd.1986.133.3.450","journal-title":"Am Rev Respir Dis"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2007.59","article-title":"Progressive preclinical interstitial lung disease in rheumatoid arthritis","volume":"168","author":"Gochuico BR","year":"2008","unstructured":"Gochuico BR, Avila NA, Chow CK, et al.. Progressive preclinical interstitial lung disease in rheumatoid arthritis. Arch Intern Med. 2008, 168:159-166. 10.1001\/archinternmed.2007.59","journal-title":"Arch Intern Med"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1378\/chest.09-0444","article-title":"Rheumatoid arthritis-associated interstitial lung disease: the relevance of histopathologic and radiographic pattern","volume":"136","author":"Kim EJ","year":"2009","unstructured":"Kim EJ, Collard HR, King TE Jr. Rheumatoid arthritis-associated interstitial lung disease: the relevance of histopathologic and radiographic pattern. Chest. 2009, 136:1397-1405. 10.1378\/chest.09-0444","journal-title":"Chest"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1378\/chest.127.6.2019","article-title":"Histopathologic pattern and clinical features of rheumatoid arthritis-associated interstitial lung disease","volume":"127","author":"Lee HK","year":"2005","unstructured":"Lee HK, Kim DS, Yoo B, Seo JB, Rho JY, Colby TV, Kitaichi M. Histopathologic pattern and clinical features of rheumatoid arthritis-associated interstitial lung disease. Chest. 2005, 127:2019-2027. 10.1378\/chest.127.6.2019","journal-title":"Chest"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201004-0622OC","article-title":"Rheumatoid arthritis-interstitial lung disease-associated mortality","volume":"183","author":"Olson AL","year":"2011","unstructured":"Olson AL, Swigris JJ, Sprunger DB, et al.. Rheumatoid arthritis-interstitial lung disease-associated mortality. Am J Respir Crit Care Med. 2011, 183:372-378. 10.1164\/rccm.201004-0622OC","journal-title":"Am J Respir Crit Care Med"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1002\/art.27405","article-title":"Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study","volume":"62","author":"Bongartz T","year":"2010","unstructured":"Bongartz T, Nannini C, Medina-Velasquez YF, et al.. Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study. Arthritis Rheum. 2010, 62:1583-1591. 10.1002\/art.27405","journal-title":"Arthritis Rheum"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1183\/09059180.00008014","article-title":"Rheumatoid arthritis-associated lung disease","volume":"24","author":"Shaw M","year":"2015","unstructured":"Shaw M, Collins BF, Ho LA, Raghu G. Rheumatoid arthritis-associated lung disease. Eur Respir Rev. 2015, 24:1-16. 10.1183\/09059180.00008014","journal-title":"Eur Respir Rev"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1136\/ard.53.8.511","article-title":"Bronchial reactivity and airflow obstruction in rheumatoid arthritis","volume":"53","author":"Hassan WU","year":"1994","unstructured":"Hassan WU, Keaney NP, Holland CD, Kelly CA. Bronchial reactivity and airflow obstruction in rheumatoid arthritis. Ann Rheum Dis. 1994, 53:511-514. 10.1136\/ard.53.8.511","journal-title":"Ann Rheum Dis"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.4187\/respcare.01857","article-title":"Coexistence of bronchiectasis and rheumatoid arthritis: revisited","volume":"58","author":"Wilczynska MM","year":"2013","unstructured":"Wilczynska MM, Condliffe AM, McKeon DJ. Coexistence of bronchiectasis and rheumatoid arthritis: revisited. Respir Care. 2013, 58:694-701. 10.4187\/respcare.01857","journal-title":"Respir Care"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-11-304","article-title":"Risk of infections in bronchiectasis during disease-modifying treatment and biologics for rheumatic diseases","volume":"11","author":"Geri G","year":"2011","unstructured":"Geri G, Dadoun S, Bui T, Del Castillo Pinol N, Paternotte S, Dougados M, Gossec L. Risk of infections in bronchiectasis during disease-modifying treatment and biologics for rheumatic diseases. BMC Infect Dis. 2011, 11:304. 10.1186\/1471-2334-11-304","journal-title":"BMC Infect Dis"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.158.2.3941873","article-title":"Cricoarytenoiditis: CT assessment in rheumatoid arthritis","volume":"158","author":"Brazeau-Lamontagne L","year":"1986","unstructured":"Brazeau-Lamontagne L, Charlin B, Levesque RY, Lussier A. Cricoarytenoiditis: CT assessment in rheumatoid arthritis. Radiology. 1986, 158:463-466. 10.1148\/radiology.158.2.3941873","journal-title":"Radiology"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.154.5.8912776","article-title":"Bronchiolar disease in rheumatoid arthritis","volume":"154","author":"Hayakawa H","year":"1996","unstructured":"Hayakawa H, Sato A, Imokawa S, Toyoshima M, Chida K, Iwata M. Bronchiolar disease in rheumatoid arthritis. Am J Respir Crit Care Med. 1996, 154:1531-1536. 10.1164\/ajrccm.154.5.8912776","journal-title":"Am J Respir Crit Care Med"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-018-0673-x","article-title":"Obliterative bronchiolitis associated with rheumatoid arthritis: analysis of a single-center case series","volume":"18","author":"Lin E","year":"2018","unstructured":"Lin E, Limper AH, Moua T. Obliterative bronchiolitis associated with rheumatoid arthritis: analysis of a single-center case series. BMC Pulm Med. 2018, 18:105. 10.1186\/s12890-018-0673-x","journal-title":"BMC Pulm Med"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-007-0322-9","article-title":"Pleural effusion associated with rheumatoid arthritis: what cell predominance to anticipate?","volume":"27","author":"Avnon LS","year":"2007","unstructured":"Avnon LS, Abu-Shakra M, Flusser D, Heimer D, Sion-Vardy N. Pleural effusion associated with rheumatoid arthritis: what cell predominance to anticipate?. Rheumatol Int. 2007, 27:919-925. 10.1007\/s00296-007-0322-9","journal-title":"Rheumatol Int"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.4187\/respcare.02597","article-title":"Pleuro-pulmonary complications of rheumatoid arthritis","volume":"59","author":"Corcoran JP","year":"2014","unstructured":"Corcoran JP, Ahmad M, Mukherjee R, Redmond KC. Pleuro-pulmonary complications of rheumatoid arthritis. Respir Care. 2014, 59:55-59. 10.4187\/respcare.02597","journal-title":"Respir Care"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2006.03.002","article-title":"Rheumatoid pleural effusion","volume":"35","author":"Balbir-Gurman A","year":"2006","unstructured":"Balbir-Gurman A, Yigla M, Nahir AM, Braun-Moscovici Y. Rheumatoid pleural effusion. Semin Arthritis Rheum. 2006, 35:368-378. 10.1016\/j.semarthrit.2006.03.002","journal-title":"Semin Arthritis Rheum"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-74-5-665","article-title":"Empyema in rheumatoid pleuropulmonary disease","volume":"74","author":"Jones FL Jr","year":"1971","unstructured":"Jones FL Jr, Blodgett RC Jr. Empyema in rheumatoid pleuropulmonary disease. Ann Intern Med. 1971, 74:665-671. 10.7326\/0003-4819-74-5-665","journal-title":"Ann Intern Med"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1055\/s-0039-1683995","article-title":"Pulmonary complications of rheumatoid arthritis","volume":"40","author":"Farquhar H","year":"2019","unstructured":"Farquhar H, Vassallo R, Edwards AL, Matteson EL. Pulmonary complications of rheumatoid arthritis. Semin Respir Crit Care Med. 2019, 40:194-207. 10.1055\/s-0039-1683995","journal-title":"Semin Respir Crit Care Med"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2004.02.001","article-title":"Correlations between high-resolution computed tomography of the chest and clinical function in patients with rheumatoid arthritis: prospective study in 75 patients","volume":"72","author":"Zrour SH","year":"2005","unstructured":"Zrour SH, Touzi M, Bejia I, et al.. Correlations between high-resolution computed tomography of the chest and clinical function in patients with rheumatoid arthritis: prospective study in 75 patients. Joint Bone Spine. 2005, 72:41-47. 10.1016\/j.jbspin.2004.02.001","journal-title":"Joint Bone Spine"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ket475","article-title":"Vasculitis associated with rheumatoid arthritis: a case-control study","volume":"53","author":"Makol A","year":"2014","unstructured":"Makol A, Crowson CS, Wetter DA, Sokumbi O, Matteson EL, Warrington KJ. Vasculitis associated with rheumatoid arthritis: a case-control study. Rheumatology (Oxford). 2014, 53:890-899. 10.1093\/rheumatology\/ket475","journal-title":"Rheumatology (Oxford)"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0033-2017","article-title":"Supplemental oxygen and dypsnoea in interstitial lung disease: absence of evidence is not evidence of absence","volume":"26","author":"Schaeffer MR","year":"2017","unstructured":"Schaeffer MR, Molgat-Seon Y, Ryerson CJ, Guenette JA. Supplemental oxygen and dypsnoea in interstitial lung disease: absence of evidence is not evidence of absence. Eur Respir Rev. 2017, 26:170033. 10.1183\/16000617.0033-2017","journal-title":"Eur Respir Rev"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2013.07.004","article-title":"Rheumatoid arthritis (RA) associated interstitial lung disease (ILD)","volume":"24","author":"O'Dwyer DN","year":"2013","unstructured":"O'Dwyer DN, Armstrong ME, Cooke G, Dodd JD, Veale DJ, Donnelly SC. Rheumatoid arthritis (RA) associated interstitial lung disease (ILD). Eur J Intern Med. 2013, 24:597-603. 10.1016\/j.ejim.2013.07.004","journal-title":"Eur J Intern Med"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1177\/1759720X15612250","article-title":"Treatment of rheumatoid arthritis-associated interstitial lung disease: a perspective review","volume":"7","author":"Iqbal K","year":"2015","unstructured":"Iqbal K, Kelly C. Treatment of rheumatoid arthritis-associated interstitial lung disease: a perspective review. Ther Adv Musculoskelet Dis. 2015, 7:247-267. 10.1177\/1759720X15612250","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-014-0190-z","article-title":"Interstitial lung disease in patients with rheumatoid arthritis: spontaneous and drug induced","volume":"74","author":"Hallowell RW","year":"2014","unstructured":"Hallowell RW, Horton MR. Interstitial lung disease in patients with rheumatoid arthritis: spontaneous and drug induced. Drugs. 2014, 74:443-450. 10.1007\/s40265-014-0190-z","journal-title":"Drugs"},{"key":"ref60","article-title":"\ufeffClinical course and outcome of rheumatoid arthritis-related usual interstitial pneumonia","volume":"30","author":"Song JW","year":"2013","unstructured":"Song JW, Lee HK, Lee CK, Chae EJ, Jang SJ, Colby TV, Kim DS. \ufeffClinical course and outcome of rheumatoid arthritis-related usual interstitial pneumonia. Sarcoidosis Vasc Diffuse Lung Dis. 2013, 30:103-112.","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/144.2.291","article-title":"Azathioprine combined with prednisone in the treatment of idiopathic pulmonary fibrosis: a prospective double-blind, randomized, placebo-controlled clinical trial","volume":"144","author":"Raghu G","year":"1991","unstructured":"Raghu G, Depaso WJ, Cain K, et al.. Azathioprine combined with prednisone in the treatment of idiopathic pulmonary fibrosis: a prospective double-blind, randomized, placebo-controlled clinical trial. Am Rev Respir Dis. 1991, 144:291-296. 10.1164\/ajrccm\/144.2.291","journal-title":"Am Rev Respir Dis"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1401739","article-title":"Randomized trial of acetylcysteine in idiopathic pulmonary fibrosis","volume":"370","author":"Martinez FJ","year":"2014","unstructured":"Martinez FJ, de Andrade JA, Anstrom KJ, King TE Jr, Raghu G. Randomized trial of acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med. 2014, 370:2093-2101. 10.1056\/NEJMoa1401739","journal-title":"N Engl J Med"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1191\/0961203305lu2109oa","article-title":"Mechanisms of action of mycophenolate mofetil","volume":"14","author":"Allison AC","year":"2005","unstructured":"Allison AC. Mechanisms of action of mycophenolate mofetil. Lupus. 2005, 14:2-8. 10.1191\/0961203305lu2109oa","journal-title":"Lupus"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.121043","article-title":"Mycophenolate mofetil improves lung function in connective tissue disease-associated interstitial lung disease","volume":"40","author":"Fischer A","year":"2013","unstructured":"Fischer A, Brown KK, Du Bois RM, et al.. Mycophenolate mofetil improves lung function in connective tissue disease-associated interstitial lung disease. J Rheumatol. 2013, 40:640-646. 10.3899\/jrheum.121043","journal-title":"J Rheumatol"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/143637","article-title":"Effect and safety of mycophenolate mofetil or sodium in systemic sclerosis-associated interstitial lung disease: a meta-analysis","volume":"2012","author":"Tzouvelekis A","year":"2012","unstructured":"Tzouvelekis A, Galanopoulos N, Bouros E, et al.. Effect and safety of mycophenolate mofetil or sodium in systemic sclerosis-associated interstitial lung disease: a meta-analysis. Pulm Med. 2012, 2012:143637. 10.1155\/2012\/143637","journal-title":"Pulm Med"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1002\/art.38322","article-title":"Methotrexate and lung disease in rheumatoid arthritis: a meta-analysis of randomized controlled trials","volume":"66","author":"Conway R","year":"2014","unstructured":"Conway R, Low C, Coughlan RJ, O'Donnell MJ, Carey JJ. Methotrexate and lung disease in rheumatoid arthritis: a meta-analysis of randomized controlled trials. Arthritis Rheumatol. 2014, 66:803-812. 10.1002\/art.38322","journal-title":"Arthritis Rheumatol"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ken356","article-title":"Variation of immunological response in methotrexate-induced pneumonitis","volume":"47","author":"Chikura B","year":"2008","unstructured":"Chikura B, Sathi N, Lane S, Dawson JK. Variation of immunological response in methotrexate-induced pneumonitis. Rheumatology (Oxford). 2008, 47:1647-1650. 10.1093\/rheumatology\/ken356","journal-title":"Rheumatology (Oxford)"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.26112","article-title":"TNF-\u03b1-induced NF-\u03baB activation promotes myofibroblast differentiation of LR-MSCs and exacerbates bleomycin-induced pulmonary fibrosis","volume":"233","author":"Hou J","year":"2018","unstructured":"Hou J, Ma T, Cao H, et al.. TNF-\u03b1-induced NF-\u03baB activation promotes myofibroblast differentiation of LR-MSCs and exacerbates bleomycin-induced pulmonary fibrosis. J Cell Physiol. 2018, 233:2409-2419. 10.1002\/jcp.26112","journal-title":"J Cell Physiol"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1007\/s10165-006-0491-5","article-title":"Development of interstitial pneumonia in a rheumatoid arthritis patient treated with infliximab, an anti-tumor necrosis factor alpha-neutralizing antibody","volume":"16","author":"Mori S","year":"2006","unstructured":"Mori S, Imamura F, Kiyofuji C, Sugimoto M. Development of interstitial pneumonia in a rheumatoid arthritis patient treated with infliximab, an anti-tumor necrosis factor alpha-neutralizing antibody. Mod Rheumatol. 2006, 16:251-255. 10.1007\/s10165-006-0491-5","journal-title":"Mod Rheumatol"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kel090","article-title":"Acute progression of interstitial lung disease: a complication of etanercept particularly in the presence of rheumatoid lung and methotrexate treatment","volume":"45","author":"Lindsay K","year":"2006","unstructured":"Lindsay K, Melsom R, Jacob BK, Mestry N. Acute progression of interstitial lung disease: a complication of etanercept particularly in the presence of rheumatoid lung and methotrexate treatment. Rheumatology (Oxford). 2006, 45:1048-1049. 10.1093\/rheumatology\/kel090","journal-title":"Rheumatology (Oxford)"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1002\/art.21716","article-title":"Pulmonary fibrosis in a patient with rheumatoid arthritis treated with adalimumab","volume":"55","author":"Schoe A","year":"2006","unstructured":"Schoe A, van der Laan-Baalbergen NE, Huizinga TW, Breedveld FC, van Laar JM. Pulmonary fibrosis in a patient with rheumatoid arthritis treated with adalimumab. Arthritis Rheum. 2006, 55:157-159. 10.1002\/art.21716","journal-title":"Arthritis Rheum"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ker289","article-title":"Non-infectious pulmonary complications of newer biological agents for rheumatic diseases--a systematic literature review","volume":"50","author":"Hadjinicolaou AV","year":"2011","unstructured":"Hadjinicolaou AV, Nisar MK, Bhagat S, Parfrey H, Chilvers ER, Ost\u00f6r AJ. Non-infectious pulmonary complications of newer biological agents for rheumatic diseases--a systematic literature review. Rheumatology (Oxford). 2011, 50:2297-2305. 10.1093\/rheumatology\/ker289","journal-title":"Rheumatology (Oxford)"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2010.11.002","article-title":"Interstitial lung disease induced or exacerbated by TNF-targeted therapies: analysis of 122 cases","volume":"41","author":"Perez-Alvarez R","year":"2011","unstructured":"Perez-Alvarez R, Perez-de-Lis M, Diaz-Lagares C, et al.. Interstitial lung disease induced or exacerbated by TNF-targeted therapies: analysis of 122 cases. Semin Arthritis Rheum. 2011, 41:256-264. 10.1016\/j.semarthrit.2010.11.002","journal-title":"Semin Arthritis Rheum"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.120626","article-title":"Influence of anti-TNF therapy on mortality in patients with rheumatoid arthritis-associated interstitial lung disease: results from the British Society for Rheumatology Biologics Register","volume":"69","author":"Dixon WG","year":"2010","unstructured":"Dixon WG, Hyrich KL, Watson KD, Lunt M, Symmons DP. Influence of anti-TNF therapy on mortality in patients with rheumatoid arthritis-associated interstitial lung disease: results from the British Society for Rheumatology Biologics Register. Ann Rheum Dis. 2010, 69:1086-1091. 10.1136\/ard.2009.120626","journal-title":"Ann Rheum Dis"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1378\/chest.122.3.1093","article-title":"Clinical response of rheumatoid arthritis-associated pulmonary fibrosis to tumor necrosis factor-alpha inhibition","volume":"122","author":"Vassallo R","year":"2002","unstructured":"Vassallo R, Matteson E, Thomas CF Jr. Clinical response of rheumatoid arthritis-associated pulmonary fibrosis to tumor necrosis factor-alpha inhibition. Chest. 2002, 122:1093-1096. 10.1378\/chest.122.3.1093","journal-title":"Chest"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1002\/art.21758","article-title":"Morphologic and quantitative assessment of CD20+ B cell infiltrates in rheumatoid arthritis-associated nonspecific interstitial pneumonia and usual interstitial pneumonia","volume":"54","author":"Atkins SR","year":"2006","unstructured":"Atkins SR, Turesson C, Myers JL, Tazelaar HD, Ryu JH, Matteson EL, Bongartz T. Morphologic and quantitative assessment of CD20+ B cell infiltrates in rheumatoid arthritis-associated nonspecific interstitial pneumonia and usual interstitial pneumonia. Arthritis Rheum. 2006, 54:635-641. 10.1002\/art.21758","journal-title":"Arthritis Rheum"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-eular.1355","article-title":"FRI0228 safety and efficacy of rituximab in patients with rheumatoid arthritis and lung involvement","volume":"72","author":"Becerra E","year":"2013","unstructured":"Becerra E, Cambridge G, Leandro M. FRI0228 safety and efficacy of rituximab in patients with rheumatoid arthritis and lung involvement. Ann Rheum Dis. 2013, 72:A450. 10.1136\/annrheumdis-2013-eular.1355","journal-title":"Ann Rheum Dis"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1007\/s13665-014-0080-6","article-title":"Lung transplantation for scleroderma-related lung disease","volume":"3","author":"Richardson CB","year":"2014","unstructured":"Richardson CB, Singer JP. Lung transplantation for scleroderma-related lung disease. Curr Respir Care Rep. 2014, 3:79-87. 10.1007\/s13665-014-0080-6","journal-title":"Curr Respir Care Rep"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2019.105700","article-title":"Inhibitory effects of pirfenidone on fibroblast to myofibroblast transition in rheumatoid arthritis-associated interstitial lung disease via the downregulation of activating transcription factor 3 (ATF3)","volume":"74","author":"Wu C","year":"2019","unstructured":"Wu C, Lin H, Zhang X. Inhibitory effects of pirfenidone on fibroblast to myofibroblast transition in rheumatoid arthritis-associated interstitial lung disease via the downregulation of activating transcription factor 3 (ATF3). Int Immunopharmacol. 2019, 74:105700. 10.1016\/j.intimp.2019.105700","journal-title":"Int Immunopharmacol"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1378\/chest.13-2408","article-title":"A roadmap to promote clinical and translational research in rheumatoid arthritis-associated interstitial lung disease","volume":"145","author":"Doyle TJ","year":"2014","unstructured":"Doyle TJ, Lee JS, Dellaripa PF, et al.. A roadmap to promote clinical and translational research in rheumatoid arthritis-associated interstitial lung disease. Chest. 2014, 145:454-463. 10.1378\/chest.13-2408","journal-title":"Chest"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/86867-rheumatoid-arthritis-and-associated-lung-diseases-a-comprehensive-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:45:16Z","timestamp":1707507916000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/86867-rheumatoid-arthritis-and-associated-lung-diseases-a-comprehensive-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,18]]},"references-count":80,"URL":"https:\/\/doi.org\/10.7759\/cureus.22367","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2,18]]}}}